|
Biogenerics: Challenges and Promise |
|
Biogenerics: Challenges and Promise takes an insightful look at the burgeoning biogenerics industry and helps to clarify the complicated regulations that currently govern biogeneric development in both the US and Europe.
|
|
Read more...
|
|
|
Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition |
|
The value of biological drugs indicated for autoimmune diseases, which affect up to 5% of the total world population, was roughly $11 billion in 2005. Remicade, Enbrel, Humira and Avonex currently lead the autoimmune field.
|
|
Read more...
|
|
Cancer Therapeutics: Market Insight and R&D Pipeline Analysis |
|
The intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics. This report analyzes in detail the markets for colorectal cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin’s lymphoma.
|
|
Read more...
|
|
Cancer Vaccines: Measuring Market Potential |
|
This report provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets. Vaccine product candidates are discussed within the context of the disease areas they are attempting to penetrate and include: melanoma, prostate cancer, colorectal cancer, lung cancer, breast cancer, and pancreatic cancer.
|
|
Read more...
|
|
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines and Commercial Opportunities |
|
In a market currently valued around US$42 billion, cancer chemotherapies are on course for staggering growth potential and may revolutionize cancer treatments over the next 10 years according to Spectra’s expert cancer report.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>
|
|
Page 1 of 7 |
